PA

Puthimedatty Abdul Kharim Shameena

Active Director Director DIN 11059312
DIN 11059312 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Puthimedatty Abdul Kharim Shameena

Data last updated:

Puthimedatty Abdul Kharim Shameena is a Director at Mav Institute Of Medical Sciences Private Limited (since 2025).

DIN 11059312
Primary Designation Director
First Appointment 16 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20252025Active

Board colleagues of Puthimedatty Abdul Kharim Shameena

NameDINCompanyDesignation
Ashath Vahab11059311Mav Institute Of Medical Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mav Institute Of Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Puthimedatty Abdul Kharim Shameena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Puthimedatty Abdul Kharim Shameena

Puthimedatty Abdul Kharim Shameena currently holds 1 directorship: Mav Institute Of Medical Sciences Private Limited (Director, since 16 Apr 2025).

Puthimedatty Abdul Kharim Shameena was first appointed on 16 Apr 2025 as Director at Mav Institute Of Medical Sciences Private Limited.

The current boards of Puthimedatty Abdul Kharim Shameena's companies include Ashath Vahab (Mav Institute Of Medical Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available